Geneos Wealth Management’s abrdn Healthcare Opportunities Fund THQ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $77K | Hold |
4,110
| – | – | ﹤0.01% | 1318 |
|
|
2026
Q1 | $69K | Hold |
4,110
| – | – | ﹤0.01% | 1301 |
|
|
2025
Q4 | $78.6K | Hold |
4,110
| – | – | ﹤0.01% | 1232 |
|
|
2025
Q3 | $71.1K | Buy |
4,110
+3,000
| +270% | +$51.1K | ﹤0.01% | 1242 |
|
|
2025
Q2 | $20.4K | Hold |
1,110
| – | – | ﹤0.01% | 2021 |
|
|
2025
Q1 | $22.9K | Hold |
1,110
| – | – | ﹤0.01% | 1887 |
|
|
2024
Q4 | $20.9K | Hold |
1,110
| – | – | ﹤0.01% | 1706 |
|
|
2024
Q3 | $24.5K | Hold |
1,110
| – | – | ﹤0.01% | 1488 |
|
|
2024
Q2 | $22.6K | Hold |
1,110
| – | – | ﹤0.01% | 1306 |
|
|
2024
Q1 | $22.3K | Hold |
1,110
| – | – | ﹤0.01% | 1323 |
|
|
2023
Q4 | $20.1K | Hold |
1,110
| – | – | ﹤0.01% | 1348 |
|
|
2023
Q3 | $18.8K | Hold |
1,110
| – | – | ﹤0.01% | 1389 |
|
|
2023
Q2 | $21.2K | Hold |
1,110
| – | – | ﹤0.01% | 1359 |
|
|
2023
Q1 | $20.8K | Hold |
1,110
| – | – | ﹤0.01% | 1335 |
|
|
2022
Q4 | $22K | Sell |
1,110
-1,025
| -48% | -$20.2K | ﹤0.01% | 1311 |
|
|
2022
Q3 | $38K | Sell |
2,135
-1,415
| -40% | -$28.3K | ﹤0.01% | 1117 |
|
|
2022
Q2 | $71K | Hold |
3,550
| – | – | ﹤0.01% | 1143 |
|
|
2022
Q1 | $79K | Hold |
3,550
| – | – | ﹤0.01% | 1182 |
|
|
2021
Q4 | $91K | Sell |
3,550
-2,115
| -37% | -$50.8K | ﹤0.01% | 1208 |
|
|
2021
Q3 | $128K | Sell |
5,665
-435
| -7% | -$10.5K | ﹤0.01% | 1058 |
|
|
2021
Q2 | $143K | Sell |
6,100
-435
| -7% | -$9.99K | 0.01% | 1011 |
|
|
2021
Q1 | $150K | Hold |
6,535
| – | – | ﹤0.01% | 1102 |
|
|
2020
Q4 | $140K | Buy |
6,535
+2,115
| +48% | +$40.4K | 0.01% | 988 |
|
|
2020
Q3 | $77K | Sell |
4,420
-400
| -8% | -$7.27K | ﹤0.01% | 1059 |
|
|
2020
Q2 | $83K | Hold |
4,820
| – | – | ﹤0.01% | 1004 |
|
|
2020
Q1 | $70K | Hold |
4,820
| – | – | ﹤0.01% | 977 |
|
|
2019
Q4 | $92K | Sell |
4,820
-1,541
| -24% | -$27.9K | ﹤0.01% | 978 |
|
|
2019
Q3 | $109K | Hold |
6,361
| – | – | 0.01% | 862 |
|
|
2019
Q2 | $113K | Hold |
6,361
| – | – | 0.01% | 862 |
|
|
2019
Q1 | $112K | Hold |
6,361
| – | – | 0.01% | 824 |
|
|
2018
Q4 | $106K | Buy |
6,361
+1,541
| +32% | +$27.3K | 0.01% | 824 |
|
|
2018
Q3 | $90K | Buy |
4,820
+2,820
| +141% | +$51.1K | 0.01% | 925 |
|
|
2018
Q2 | $34K | Buy |
2,000
+1,600
| +400% | +$26.8K | ﹤0.01% | 1228 |
|
|
2018
Q1 | $6K | Hold |
400
| – | – | ﹤0.01% | 1824 |
|
|
2017
Q4 | $7K | Hold |
400
| – | – | ﹤0.01% | 1751 |
|
|
2017
Q3 | $7K | Hold |
400
| – | – | ﹤0.01% | 1692 |
|
|
2017
Q2 | $7K | Hold |
400
| – | – | ﹤0.01% | 1651 |
|
|
2017
Q1 | $6K | Hold |
400
| – | – | ﹤0.01% | 1658 |
|
|
2016
Q4 | $6K | Hold |
400
| – | – | ﹤0.01% | 1599 |
|
|
2016
Q3 | $6K | Hold |
400
| – | – | ﹤0.01% | 1527 |
|
|
2016
Q2 | $6K | Hold |
400
| – | – | ﹤0.01% | 1483 |
|
|
2016
Q1 | $6K | Buy |
+400
| New | +$6.18K | ﹤0.01% | 1454 |
|
Other funds holding THQ
HBCM
PCM
WS
Geneos Wealth Management's THQ Position: Q2 2026 in Review
Geneos Wealth Management held its abrdn Healthcare Opportunities Fund (THQ) position steady in Q2 2026 at 4,110 shares worth $77K. The position accounts for ﹤0.01% of the portfolio, ranked #1318.
Geneos Wealth Management first reported a position in THQ in Q1 2016 and has held it in 42 quarters since. The position peaked at $150K in Q1 2021. 97 funds tracked by Wall St. Rank hold THQ as of Q2 2026.
- Geneos Wealth Management held 4,110 shares of abrdn Healthcare Opportunities Fund worth $77K as of Q2 2026.
- Geneos Wealth Management left its abrdn Healthcare Opportunities Fund share count unchanged in Q2 2026.
- abrdn Healthcare Opportunities Fund made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1318 holding.
- Geneos Wealth Management first reported a position in abrdn Healthcare Opportunities Fund in Q1 2016 and has held it in 42 quarters since.
- Geneos Wealth Management's abrdn Healthcare Opportunities Fund position peaked at $150K in Q1 2021.
- 97 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.